SARS_CoV_2 mutation literature information.


  Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants.
 PMID: 34207378       2021       Viruses
Introduction: The slight decrease in the neutralizing activity was linked to the S982A mutation located in the S2 domain of the Spike protein.


  A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic.
 PMID: 34207490       2021       Viruses
Abstract: Genetic analysis of whole SARS-CoV-2 genomic sequences of the aforementioned lineages revealed the presence of mutations within the S protein (L18F, DeltaH69/V70, S898F, DeltaY144, S162G, A222V, N439K, N501Y, A570D, D614G, P681H, S982A and D1118H) that confer higher transmissibility and/or antibody escape (immune evasion) upon the virus.
Introduction: Furthermore, mutations/deletions in the S-protein, such as L18F, DeltaH69/V70,
 PMID: 34217923       2021       Virology
Introduction: VOC, 202012/01) with multiple S protein mutations (deletion 69-70, deletion 144, N501Y, A570D, D614G, P681H, T716I, S982A, D1118H) spread rapidly across South East England and London.


  The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom.
 PMID: 34220844       2021       Frontiers in immunology
Introduction: Since December 2020, the VOC-202012/01 (VOC-202012/01 variant, including multiple mutations 69-70del, 144/145del, N501Y, A570D, P681H, T716I, S982A, and D1118H) has been increasing rapidly.
Method: The spike protein was modeled based on the Protein Data Bank coordinate set 6VXX, showing the mutation N501Y in S1 and S982A in S2.
Result: Structure modeling of the mutation N501Y in S1 and S982A in S2 was showed asFigure 2B .

Browser Board

 Co-occurred Entities




   Filtrator